GPC4 and polycystic ovary syndrome: They concluded that glypican-4 levels were higher in women with PCOS than those of controls and correlated with cardiovascular risk factors, in particular fat distribution, in spite of the low mean BMI of 22 kg/m2 and the absence of lipid disorders in the evaluated subjects.